This trial is active, not recruiting.

Condition diabetes mellitus
Sponsor HaEmek Medical Center, Israel
Start date January 2005
End date December 2005
Trial size 500 participants
Trial identifier NCT00399347, 4940706


The prevalence and incidence of diabetes has been reported to vary among populations.Immigrants groups as that have undergone significant life-style changes tend to develop diabetes within a short time. The aim of the study is to assess the prevalence of diabetes mellitus in Ethiopian population ,15-20 years after immigration in Israel.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model defined population
Primary purpose screening
Time perspective cross-sectional

Eligibility Criteria

Male or female participants at least 33 years old.

Inclusion Criteria: - Male and female Ethiopians Jews who immigrate in Israel in 1991 and were 18 years old or more at immigration. Exclusion Criteria: - Type 1 diabetes Mellitus

Additional Information

Official title Prevalence of Diabetes Mellitus in Ethiopian Community in Israel: an Update
Principal investigator Avraham Ishay MD
Description The study will be conducted in three primary care clinics of the Jezreel Valley (Omer, Givat Hamore and Afula Illit). The computerized medical charts of 500 Ethiopian adults will be reviewed. The following information will be obtained: age, date of arrival in Israel, known history of diabetes, hyperlipidemia, hypertension or other disease, drug therapy, body weight, blood pressure. Following laboratory data will be retrieved: blood glucose, HbA1c, lipid levels , creatinine and uric acid. The criteria used for the definition of diabetes will be based on the criteria proposed by the American Diabetes Association .
Trial information was received from ClinicalTrials.gov and was last updated in November 2006.
Information provided to ClinicalTrials.gov by HaEmek Medical Center, Israel.